ETF Managers Group’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $394K | Sell |
44,598
-127,788
| -74% | -$1.13M | 0.01% | 503 |
|
|
2022
Q4 | $1.32M | Buy |
172,386
+130,225
| +309% | +$995K | 0.06% | 129 |
|
|
2022
Q3 | $300K | Sell |
42,161
-2,774
| -6% | -$19.7K | 0.01% | 554 |
|
|
2022
Q2 | $369K | Buy |
44,935
+1,988
| +5% | +$16.3K | 0.01% | 568 |
|
|
2022
Q1 | $596K | Buy |
42,947
+293
| +0.7% | +$4.07K | 0.01% | 435 |
|
|
2021
Q4 | $1.21M | Sell |
42,654
-8,745
| -17% | -$248K | 0.02% | 255 |
|
|
2021
Q3 | $1.67M | Buy |
51,399
+10,014
| +24% | +$325K | 0.03% | 216 |
|
|
2021
Q2 | $1.75M | Sell |
41,385
-1,342
| -3% | -$56.6K | 0.03% | 234 |
|
|
2021
Q1 | $1.61M | Sell |
42,727
-4,281
| -9% | -$161K | 0.03% | 220 |
|
|
2020
Q4 | $2.79M | Sell |
47,008
-2,606
| -5% | -$155K | 0.06% | 164 |
|
|
2020
Q3 | $2.38M | Buy |
49,614
+31,659
| +176% | +$1.52M | 0.08% | 151 |
|
|
2020
Q2 | $827K | Buy |
+17,955
| New | +$827K | 0.03% | 203 |
|